The New Biopharmaceutical Blueprint
by IBM Corp.
Bringing a pharmaceutical or biologic product to market takes more than just good science. It takes an agile business to respond to the changing market dynamics. Research and development (R&D) is under pressure to bring new treatments to market faster and extend its reach in global markets. Likewise, manufacturing needs to incorporate more efficient, quality-centric processes that scale across regions and partners. At the same time, sales and marketing need to address regulatory demands by re-evaluating how they manage the increasing number of channels and partners. The challenges of integrating technologies can hamper all of these efforts. Service-oriented architecture (SOA) can serve as the new blueprint for aligning business and IT. This paper is intended for business executives and explores how SOA can help enterprises effectively achieve business flexibility within a compliant environment.
| Published: | 2008 |
| Format: | |
| Length: | 24 pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
